Medicine and Dentistry
Infection
68%
Polyradiculoneuropathy
62%
Respiratory Failure
47%
Immunoglobulin
44%
Guillain-Barré Syndrome
42%
Weakness
35%
Artificial Respiration
33%
Cohort Study
31%
Disease Course
31%
Cerebrospinal Fluid
30%
Prospective Cohort Study
30%
Cohort Effect
30%
Cohort Analysis
29%
Diseases
29%
Peripheral Nerve
27%
Electrodiagnosis
23%
Clinical Feature
22%
Disease Severity
19%
Zika Virus
18%
Neurology
18%
Ganglioside
17%
Electrophysiology
16%
Motor Nerve
16%
Plasma Exchange
15%
Compound Muscle Action Potential
15%
Placebo
15%
COVID-19 Vaccination
15%
Chronic Inflammatory Demyelinating Polyneuropathy
15%
Neuropathy
14%
Nerve Conduction Study
13%
Virus Infection
12%
Campylobacter Enteritis
11%
Treatment Response
11%
Low and Middle Income Countries
11%
Pediatrics
11%
Clinical Guideline
11%
Differential Diagnosis
11%
Observational Study
11%
Clinician
10%
Glycolipid
10%
Health Care Cost
10%
Intensive Care Unit
10%
Facial Nerve Paralysis
9%
Adverse Event
8%
Mycoplasma Pneumonia
8%
Nonoxinol 9
8%
Case-Control Study
8%
Delayed Diagnosis
7%
Enterovirus D68
7%
Prospective Study
7%
Immunology and Microbiology
Intravenous Immunoglobulin
88%
Guillain-Barré Syndrome
71%
Campylobacter Jejuni
64%
Ganglioside GM1 Antibody
31%
Cerebrospinal Fluid
27%
Neurofilament
26%
Molecular Mimicry
24%
Light Chain
24%
Titer
24%
Blood Plasma
23%
Cranial Nerve
22%
Autoantibodies
21%
Arbovirus
20%
Immunoglobulin G
20%
B Cell
18%
Mycoplasma pneumoniae
18%
Immunoglobulin M
18%
Antibody Titer
17%
Serotype
16%
Epitope
16%
Zika Virus
16%
Antibody Response
16%
Viral Disease
15%
Myelitis
15%
Transverse Myelitis
15%
Glycosylation
15%
Antiganglioside Antibodies
13%
Cytomegalovirus
13%
Cross Reacting Antibody
12%
Peripheral Nerve
12%
Neuromuscular Junction
11%
Muscle
11%
Limb
9%
Infectious Agent
9%
Dengue Virus
9%
Epstein Barr Virus
9%
Campylobacter
9%
Rituximab
9%
Artificial Neural Network
9%
Nerve Conduction
9%
Autoimmune Disease
9%
Central Nervous System
8%
Humoral Immunity
8%
Immune Response
8%
Immunoglobulin G1
8%
Prevalence
8%
Enterovirus D68
8%
Dynamics
7%
CD38
7%
Daratumumab
7%
Neuroscience
Intravenous Immunoglobulin
100%
Electrodiagnosis
52%
Neuropathy
36%
Peripheral Nerve
34%
Blood Plasma
33%
Guillain-Barre Syndrome
30%
Nerve Conduction Study
29%
Ganglioside
26%
Neuromuscular Junction
21%
Ganglioside GM1 Antibody
20%
Cytomegalovirus
20%
Polyneuropathy
16%
Immunoglobulin G
15%
Cranial Nerve
15%
Latrotoxin
15%
SARS Coronavirus
15%
Transverse Myelitis
15%
Myelitis
15%
Action Potential
15%
Neurofilament Light Chain
14%
Ataxia
12%
Contactin 1
12%
Ganglioside Antibody
12%
Placebo
9%
Neuromuscular
9%
Electrophysiology
9%
Rituximab
8%
Leukocyte
8%
Nonoxynol-9
7%
Mannose Binding Lectin
7%
Synaptic Transmission
7%
Nerve Excitability
7%
Mannose
7%
Encephalitis
7%
Galactosylceramide
7%
Contactin
7%
Autoimmune Disease
7%
Synthetase
7%
Dysarthria
7%
Synapsin I
7%
Flaccid Paralysis
7%
Pharmacokinetics
7%
Comorbidity
7%
Randomized Controlled Trial
7%
Mechanical Ventilation
7%
Magnetic Resonance Imaging
7%
Nerve Block
7%
Acetylcholine Release
6%
Ophthalmoparesis
6%
Nervous System Disorder
5%